Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CymaBay Therapeutics, Inc. | 0 | reported | 22 Mar 2024 | tx 114+2,078,468−2,086,014 |
| 89bio, Inc. | 0 | reported | 30 Oct 2025 | tx 8+149,100−149,100 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Oct 2025 | TENDER | 89bio, Inc. | 25,000 | — | |
| 30 Oct 2025 | OTHER | 89bio, Inc. | 56,400 | 0.00 USD | deriv |
| 30 Oct 2025 | OTHER | 89bio, Inc. | 67,700 | 0.00 USD | deriv |
| 03 Feb 2025 | GRANT_AWARD | 89bio, Inc. | 56,400 | 0.00 USD | deriv |
| 21 Jan 2025 | PURCHASE | 89bio, Inc. | 5,000 | 6.55 USD | |
| 22 Jan 2025 | PURCHASE | 89bio, Inc. | 10,000 | 6.71 USD | |
| 05 Dec 2024 | PURCHASE | 89bio, Inc. | 10,000 | 8.00 USD | first after silence |
| 05 Aug 2024 | GRANT_AWARD | 89bio, Inc. | 67,700 | 0.00 USD | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 15,000 | — | |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 31,938 | — | |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 91,666 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 51,750 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 44,084 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 97,222 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 146,875 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 118,625 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 328,299 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 112,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 225,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 300,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 172,891 | — | deriv |
| 24 Jan 2024 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 31,938 | 0.00 USD | |
| 24 Jan 2024 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 118,625 | 0.00 USD | deriv |
| 19 Jan 2024 | SALE | CymaBay Therapeutics, Inc. | 1,916 | 23.66 USD | |
| 19 Jan 2024 | SALE | CymaBay Therapeutics, Inc. | 3,125 | 23.68 USD |
2 purchases reported after at least 12 months of silence — most recent on 05 Dec 2024.